| [1] |
家族性高胆固醇血症筛查与诊治中国专家共识[J]. 中华心血管病杂志, 2018, 46(2):99-103.
|
| [2] |
SHI Z, YUAN B, ZHAO D, et al. Familial hypercholesterolemia in China:prevalence and evidence of underdetection and undertreatment in a community population[J]. Int J Cardiol, 2014, 174(3):834-836.
DOI
URL
|
| [3] |
FREDIROCKSON D S, LEVY R I. The metabolic basis of inherited disease[M]. New York: McGraw-Hill,1972.
|
| [4] |
CUCHEL M, BRUCKERT E,GINSBERG H N,et al.
|
|
Homozygous familial hypercholesterolaemia:new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society[J]. Eur Heart J, 2014, 35(32):2146-2157.
DOI
URL
|
| [5] |
王丹颖, 张艳敏, 车凤玉, 等. 纯合型家族性高胆固醇血症家系基因型与表型分析[J]. 中华儿科杂志, 2020,(2):101-106.
|
| [6] |
GALICIA-GARCIA U, BENITO-VICENTE A, URIBE K B, et al. Mutation type classification and pathogenicity assignment of sixteen missense variants located in the EGF-precursor homology domain of the LDLR[J]. Sci Rep, 2020, 10(1):1727.
DOI
URL
|
| [7] |
SETIA N, SAXENA R, SAWHNEY J P S, et al. Familial hypercholesterolemia:cascade screening in children and relatives of the affected[J]. Indian J Pediatr, 2018, 85(5):339-343.
DOI
URL
|
| [8] |
陈晨, 陆志强. 家族性高胆固醇血症(FH)致病基因的研究进展[J]. 复旦学报(医学版), 2012, 39(2):207-211.
|
| [9] |
孙洋, 赵红. 家族性高胆固醇血症分子遗传学研究进展[J]. 心血管病学进展, 2019, 40(3):309-313.
|
| [10] |
GOLDSTEIN J L, BROWN M S. The LDL receptor[J]. Arterioscler Thromb Vasc Biol, 2009, 29(4):431-438.
DOI
PMID
|
| [11] |
陈宏, 袁施彬. 低密度脂蛋白在脂蛋白代谢中的作用及其调控[J]. 中国畜牧杂志, 2010, 46(19):72-76.
|
| [12] |
GIDDING S S, CHAMPAGNE M A, DE FERRANTI S D, et al. The agenda for familial hypercholesterolemia:a scientific statement from the American Heart Association[J]. Circulation, 2015, 132(22):2167-2192.
DOI
URL
|
| [13] |
AKIOYAMEN L E, GENEST J,SHAN S D,et al.
|
|
Estimating the prevalence of heterozygous familial hypercholesterolaemia:a systematic review and meta-analysis[J]. BMJ Open, 2017, 7(9):e016461.
|
| [14] |
KORNEVA V A, KUZNETSOVA T Y, MURTAZINA R Z, et al. The familial hypercholesterolemia caused by a novel human low density lipoprotein receptor gene mutation c.1327 T>C(p.W433R)[J]. Kardiologiia, 2017, 57(2):12-16.
|
| [15] |
JIANG L, SUN L Y, PAN X D, et al. Characterization of the unique Chinese W483X mutation in the low-density lipoprotein-receptor gene in young patients with homozygous familial hypercholesterolemia[J]. J Clin Lipidol, 2016, 10(3):538-546.e5.
DOI
URL
|
| [16] |
SUSAN-RESIGA D, GIRARD E, KISS R S, et al. The proprotein convertase subtilisin/kexin type 9-resistant R410S low density lipoprotein receptor mutation:a novel mechanism causing familial hypercholesterolemia[J]. J Biol Chem, 2017, 292(5):1573-1590.
DOI
URL
|
| [17] |
RODRÍGUEZ-JIMÉNEZ C, PERNÍA O, MOSTAZA J, et al. Functional analysis of new variants at the low-density lipoprotein receptor associated with familial hypercholesterolemia[J]. Hum Mutat, 2019, 40(8):1181-1190.
|
| [18] |
WANG H, XU S, SUN L, et al. Functional characterization of two low-density lipoprotein receptor gene mutations in two Chinese patients with familial hypercholesterolemia[J]. PLoS One, 2014, 9(3):e92703.
|
| [19] |
THEDREZ A, BLOM D J, RAMIN-MANGATA S, et al. Homozygous familial hypercholesterolemia patients with identical mutations variably express the LDLR(low-density lipoprotein receptor):implications for the efficacy of evolocumab[J]. Arterioscler Thromb Vasc Biol, 2018, 38(3):592-598.
DOI
URL
|
| [20] |
LEDE V, FRANKE C, MEUSEL A, et al. Severe atherosclerosis and hypercholesterolemia in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptor[J]. PLoS One, 2016, 11(12):e0167888.
|
